New drug halves transplant`s deadly side-effect
Washington: A new drug halves the risk of serious and often deadly side-effect of lifesaving bone marrow transplant treatments, according to a new finding.
The study combined vorinostat with standard drugs given after transplant, bringing down the percentage of patients developing graft-versus-host disease (GVHD) to 21, compared to 42 percent of patients who did with standard medications alone.
"GVHD is the most serious complication from transplant that limits our ability to offer it more broadly. Current prevention strategies have remained mostly unchanged over the past 20 years," says study co-author Sung Choi, assistant professor of paediatrics at the University of Michigan Medical School.
GVHD is characterized by the transplanted stem cells producing immune cells that attack the recipient`s body. The new immune cells treat the patient`s normal cells as foreign invaders and begin to damage the patient`s organs, according to a Michigan statement.
Vorinostat is currently approved by the US Food and Drug Administration to treat certain types of cancer. But Michgian researchers, led by senior study author Pavan Reddy, found in lab studies that the drug had anti-inflammatory effects as well.
Participants were older adults undergoing a reduced-intensity bone marrow transplant with cells donated from a relative. They received standard drug used post transplant to prevent GVHD. They also received vorinostat as a pill.
Researchers found vorinostat was safe and tolerable with manageable side-effects. Besides, rates of patient death and cancer relapse among the study participants were similar to historical averages. The results mirror those found in the laboratory using mice.
These findings were presented on Sunday at the 54th Annual Meeting of the American Society of Hematology.
More from India
More from World
More from Sports
More from Entertaiment
- DNA: Harmful chemicals found in Maggi, Nestle India still in denial mode
- CM Kejriwal shortlists 39 'unwanted' IAS officers in Delhi
- Rajasthan: Gujjars revive reservation agitation, block rail track
- DNA: Modi-led NDA govt's hits and misses in one year
- J Jayalalithaa sworn-in as Chief Minister of Tamil Nadu
- Zee Media Exclusive interview with Congress leader Kamal Nath
- ISIS to buy first nuclear weapon from Pak?
- Mumbai: CCTV captures assailant with gun at Film City
- Dr Subhash Chandra Show: Aspiring for more than what you have!
- BJP now central pole of Indian politics: Arun Jaitley
- Maharashtra FDA sends Maggi noodles for lab testing
- Mathura SSP receives death threat letter, message for PM Modi
- See what can Maggi do to your health!
- Watch: Fast N Facts @ 7:30pm
- Delhi: Two killed in road accident in New Ashok Nagar
- IPL 2015, Qualifier 2: CSK vs RCB - As it happened...
- India to soon have its own space shuttle!
- PM Narendra Modi graces Digvijay Singh's son wedding reception
- Goa Board SSC Exam Results 2015 announced
- Rahul Gandhi to pressurise govt to act on one-rank-one-pension issue
- ISIS close to buying nuclear weapon from Pakistan?
- CBSE 12th Results 2015: CBSE Board Cbse.nic.in & cbseresults.nic class 12th XII board exam Results 2015 date announced
- Manohar Parrikar visits forward areas along LoC, reviews security situation
- There will be no delay in appointing CIC, CVC: Jitendra Singh
- Credibility of Prime Minister's Office restored by BJP, says Arun Jaitley
- ISIS justifies raping slave girls, says Michelle Obama is 'worth $40'
- CBSE Board 10th Results 2015: Cbse.nic.in & Cbseresults.nic class 10th X board exam results 2015 date announced
- Arvind Kejriwal to highlight AAP govt's 100 days work on Monday
- 'Unhappy' Celina Jaitley asks Sunny Leone to move out?
- BJP's plan for one-year celebration: 200 big rallies, 5,000 public meetings